Helping menthol cigarette smokers quit through a targeted campaign
Amplifying the menthol cigarette ban’s impact in priority populations with a quit smoking campaign
This study is testing a special quit smoking campaign for Black and LGB smokers to see how well it helps them stop smoking menthol cigarettes, especially with a new ban on these cigarettes coming up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10934525 on NIH RePORTER |
What this research studies
This research aims to enhance the impact of a proposed ban on menthol cigarettes by implementing a quit smoking campaign specifically designed for priority populations, including Black and LGB smokers. The project will develop tailored messaging through expert feedback and focus groups, followed by a randomized controlled trial (RCT) to assess the effectiveness of the campaign. Participants will receive tools and support to help them quit smoking altogether, rather than switching to other cigarette types. The study will also evaluate the overall impact of the menthol ban on cigarette purchases.
Who could benefit from this research
Good fit: Ideal candidates for this research are menthol cigarette smokers, particularly those who identify as Black or LGB.
Not a fit: Patients who do not smoke menthol cigarettes or who are not part of the targeted populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce smoking rates among menthol cigarette users, particularly in underserved populations.
How similar studies have performed: Previous research has shown that targeted smoking cessation campaigns can effectively reduce smoking rates in specific populations, suggesting potential success for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Hall, Marissa — Univ of North Carolina Chapel Hill
- Study coordinator: Hall, Marissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.